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Occupational exposure to high-molecular-weight allergens is a risk factor for the development and pathogenesis of IgE-mediated
respiratory disease. In some occupational environments, workers are at an increased risk of exposure to fungal enzymes used in
industrial production. Fungal enzymes have been associated with adverse health eﬀects in the work place, in particular in baking
occupations. Exposure-response relationships have been demonstrated, and atopic workers directly handling fungal enzymes are
at an increased risk for IgE-mediated disease and occupational asthma. The utilization of new and emerging fungal enzymes in
industrial production will present new occupational exposures. The production of antibody-based immunoassaysis necessary for
the assessment of occupational exposure and the development of threshold limit values. Allergen avoidance strategies including
personalprotective equipment, engineering controls,protein encapsulation,andreduction ofairborneenzyme concentrations are
required to mitigate occupational exposure to fungal enzymes.
1.Introduction
In the United States, the 2010 civilian workforce accounted
for 139 million people [1]w h os p e n du pt oaq u a r t e r
of their lifetime and half of their waking lives at work
[2]. With changes in the global market, particularly with
the rise of biotechnology, new occupational hazards have
emerged. Approximately, 200 biotic (organisms or particles
of viral, prokaryote, or eukaryote origin) and an even greater
number of abiotic (physical and chemical) agents have
been associated with adverse health outcomes. In certain
occupational settings, particularly those engaged in handling
puriﬁed microbial proteins in baking and manufacturing
sectors, workers are at increased risk of becoming sensitized
and developing respiratory disease.
Occupational asthma (OA) is the most common respi-
ratory disease reported in the workplace [3–8]. OA has been
deﬁnedaseitherirritant inducedorimmunemediated[6,7].
Immunologically mediated OA accounts for approximately
90% of cases [9], but the severity of disease is dependent
on the concentration, route, agent of exposure, and the
latency period [6, 7]. Both high- and low-molecular-weight
antigenscaninduceOA,buttheimmunological mechanisms
are distinctly diﬀerent. High-molecular-weight allergens are
generally proteins that are greater than 5 kDa, and produc-
tion of immunoglobulin E (IgE) results in the release of
mediators from mast cells and eosinophils [6, 7].
More than 250 high-molecular-weight allergens that
induce OA have been identiﬁed [4, 6, 7]. Many are derived
from animals or plants, and exposure usually involves
mixtures of many proteins [4, 6]. Occupations where
high-molecular-weight allergens have been characterized
include seafood processing (tropomysin), dairy, poultry,
citrus, greenhouse, baking, healthcare (latex), pharmaceuti-
cal (drugs), and detergent manufacturing (fungal enzymes)
[6]. Some of the best examples of high-molecular-weight
occupational allergens are the fungal enzymes. They are
particularly suited for study because they are often used
as puriﬁed preparations in baking, food, detergent, textile,
and pharmaceutical industries [6, 10]. In this paper, we
will focus on the fungal enzymes as model high-molecular-
weight allergens in industrial settings and describe the
main enzymes that have been associated with occupational
sensitization and asthma. Identiﬁcation of emerging fungal
enzymes in manufacturing and biotechnology industries is
discussed as well as new methods to detect and quantify2 Journal of Allergy
Table 1: Fungal enzymes utilized in diﬀerent industries and associationswith occupational sensitization.
Industry
Fungal Enzyme
Characterized occupational allergen Uncharacterized occupational allergen
Agriculture Protease, lipase
Animal feed α-amylase, cellulase, lipase, phytase, protease, and
xylanase Beta-glucanase∗, endo-xylanase
Pulp and paper
production Cellulase, hemicellulase, lipase, and xylanase Esterase∗, laccase, lignin peroxidase, manganese
peroxidase, pectinase∗, and mannose
Waste management Lipase Esterase∗, cytochrome P450, laccase, lignin peroxidase,
manganese peroxidase, and monooxygenase
Biotechnology α-amylase, cellulase, glucoamylase, hemicellulase, and
protease
Cytochrome P-450 monooxygenase, glucose oxidase,
glutathione-transferase∗, lignin peroxidase, and
manganese peroxidase,
Detergent α-amylase, cellulase, lipase, and protease
Food processing α-amylase, cellulase, glucoamylase, lactase, lipase,
protease, and xylanase Glucose isomerase,invertase, and pectinase∗
Biofuels α-amylase, cellulase, glucoamylase, protease, and
xylanase
Bakery α-amylase, cellulase, glucoamylase, hemicellulase,
lipase, protease, and xylanase Glucose oxidase, lipoxygenase
Brewing and wine
production Cellulase, glucosidase, protease, and xylanase Alpha-acetolactate decarboxylase, beta-glucanase∗,a n d
pectinase∗
Pharmaceutical Lactase, lipase, and protease Alpha-galactosidase∗, catalase∗, cytochrome P450
oxygenase, and glutathione transferase∗
Textile α-amylase, cellulase, lipase, protease, and xylanase Catalase∗
Leather processing Lipase, protease
Hygiene products Glucoamylase, protease Catalase, ∗glucose oxidase
Adapted from Baur [10] and from the Concordia University Genomics Project website: https://fungalgenomics.concordia.ca/home/indappl.php.
∗Denotes fungal enzymes associated with allergic sensitizationin other fungal bioaerosols or environmental allergens.
fungal enzymes in the occupational environment. Methods
to avoid fungal allergens in the workplace are additionally
covered.
2.FungalEnzymes inOccupationalDisease
The industrial utility of fungi has been well known since
antiquity. In addition to the role of fungi as saprophytes
in the environment, many species have commercial use,
for example, mushrooms as food sources, ingredients in
food preparation (cheese ﬂavoring Penicillium roqueforti),
alcoholic fermentation, and the conversion of sugars in
bread dough to carbon dioxide (Saccharomyces cerevisiae).
In Asia, Aspergillus oryzae is an essential ingredient for the
production of soy sauce and the fermented drink, sake.
Rhizopus spp. secrete a wide variety of enzymes including
cellulolytic, proteolytic, lipolytic, and pectinolytic enzymes
that are used in the production of various foods such as
Tempe from Indonesia [46]. Rhizopus oryzae has also been
identiﬁed as a biocatalyst for biodiesel fuel production [47].
Other fungi such as Yarrowia lipolytica have more recent
applications in the biodegradation of industrial products
[48]. Advances in industrial enzymology following World
WarIIhaveenabledresearchers toidentifyandutilizevarious
enzymes and proteases that fungi produce to break down
carbohydrate and lignin containing plant material in the
environment [49]. To date, close to 200 fungal enzymes have
been puriﬁed from fungal cultures and the biochemical and
catalytic properties characterized [10, 50]. These enzymes
have great utility in pharmaceutical, agricultural, food,
paper, detergent, textile, waste treatment, and the petroleum
industries.
Industrial fungal enzymes are high-molecular-weight
proteins that are catalysts [10, 49]. A description of the
common enzymes used in various industries is presented
in Table 1. The most widely used enzymes of occupational
importance are derived from the genus Aspergillus and
include α-amylase, xylanase, and cellulase. A summary of
the proteomicand immunologic propertiesofthese enzymes
is presented in Table 2. Other enzymes are also utilized
from rhizosphere fungal species belonging to the genera
Rhizopus and Humicola (Table 2). These enzymes usually
have intracellular or other functional roles associated with
apical hyphal growth. It is uncommon for individuals in the
general population to be exposed and sensitized to these
antigens. In fact, in the general population, the prevalence
of sensitization to fungal enzymes has been reported to be as
low as 1%and as high as 15% [22, 51].However, in theoccu-
pational environment, workers that handle puriﬁed fungal
enzymes are at an increased risk of becoming sensitized to
enzymes [10, 23, 24, 42, 52–56]. This is especially the case
for workers whose occupation requires debagging, sieving,
weighing, dispensing, and mixing enzymes [24, 53–56].
Eight-hour time-weighted average exposures demonstrateJournal of Allergy 3
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that occupations weighing the enzyme preparations have
the lowest average exposure compared to those workers that
sieve [24]. These workers are often exposed to levels of dust
that exceed 4mgm−3, the threshold limit value (TLV) for
inhalable dust [57]. For other industrial environments that
uselipaseandcelluloseinproduction,occupationalexposure
is highest in production areas and laboratories [42].
Adverse health eﬀects associated with enzyme exposure
are well characterized in the baking industry. In some
countries,bakeryexposurestoenzymesareoneoftheleading
causes of occupational allergy [58]. Fungal enzymes are
commonly used as baking additives to improve the dough,
increase shelf life, and decrease production time [19, 49,
59]. Airborne concentrations ranging from 5.3ngm−3 to
200ngm−3 have been reported in occupational environ-
ments [12, 59, 60]. Occupational sensitization to fungal
enzymes was ﬁrst reported by Flindt [61]. Later, Baur et
al. [62] demonstrated IgE sensitization in workers handling
these products. Since the original study, fungal enzymes
have been identiﬁed as potent allergens in the occupa-
tional environment [25, 26]. Prevalence of sensitization to
Aspergillus enzymes ranges from 8% for glucoamylase [13],
11% for xylanase [13], 13% for cellulase [13] ,a n du pt o
34% for α-amylase [19, 27]. Sensitization to α-amylase in
bakeryworkersresultsindecreasedpeakexpiratoryﬂow[63–
66]a n dO A[ 20, 28, 67]. In one report, workers exposed
to fungal enzymes induced an immediate bronchospastic
reaction [49]. In the United States, the prevalence of
work-related wheeze, runny nose, frequent sneezing, and
speciﬁc IgE to fungal enzymes was signiﬁcantly higher
amonghighlyexposed workers[68].However,otherirritant-
induced mechanisms associated with high total dust levels
havealso beenreported in a cohort ofBritish bakers[29, 56].
To date, atopy has been hypothesized to be an important risk
factor for OA to fungal enzymes.
Occupational exposure to enzymes has been demon-
strated in other industries including manufacturing [41, 53,
69], pharmaceutical [25, 38], food processing [70], animal
feed, and biotechnology [43]. Like in baking environments,
workers handling or in direct contact with fungal enzymes
and with a history of atopy are at increased risk of becoming
sensitized [10, 23, 24, 42, 52–56]. Sensitization to proteolytic
enzymes has also been demonstrated in the manufacture of
detergents [53, 71]. In the future, additional uses for fungal
enzymesinindustrialenvironmentswillbeidentiﬁed.Recent
examples include the use of α-amylase and glucoamylase for
the production of ethanol in the biofuel industry [72, 73].
If proper methods of exposure prevention are not followed
and exposure is not monitored in these industries, it is
possible that new groups of workers will suﬀer adverse
health outcomes and become sensitized to enzymes. In the
following sections we describe the major fungal enzymes,
prevalence of sensitization, and occupational environment
that they are most likely to be encountered.
3.FungalEnzyme Allergens
3.1. α-Amylase. Fungal amylase is the most well-charac-
terizedfungalenzymeusedintheoccupationalenvironment.
Originally discovered by Takamine in 1884 [49], bakers
have used α-amylase as a supplement to cereal ﬂour to
improve carbohydrate fermentation by yeasts and ultimately
the quality of the bread [49]. α-amylase cleaves long-chain
carbohydrates into simpler sugars including maltose [49].
Derived from A. oryzae, α-amylase is a 478 amino acid gly-
coprotein with a molecular weight of 53kDa (Table 2;[ 6]).
Occupational sensitization to α-amylase was ﬁrst reported
by Flindt [61] and has subsequently been identiﬁed as an
allergen in baking [74], pharmaceutical [25], animal feed
[12], and biotechnology industries [43]. The allergen was
originally designated Asp o 2 by the International Union
of Immunological Societies (IUIS) Allergen Nomenclature
Subcommittee but now has been redesignated Asp o 21 [27].
Since this preliminary work, α-amylase has been identiﬁed
as one of the principle sensitizers in large-scale bakeries [24,
56]. The prevalence of sensitization among bakers is variable
and ranges from 0.9% to 34% [13, 18, 19, 21, 23, 24, 27–
35, 54, 66, 67, 75]. Concentrations as high as 40ngm−3
have been reported in baking environments [60]; however,
α-amylase concentrations in the low ngm−3 range have been
associated with an increased frequency of sensitization [58].
The most common tasks associated with α-amylase
exposure involve dispensing, sieving, weighing and mixing
[55, 56, 60]. Exposures that exceed the maximum exposure
limit for ﬂour dust in the United Kingdom were identi-
ﬁed in mixing, weighing [54], and dispensing operations
[55]. The prevalence of sensitization to α-amylase is 9.9
times greater among workers in high-exposure categories
compared to those workers in low-exposure categories [55].
Aerosolized particle size distribution analysis in baking
environments demonstrated that workers are exposed to α-
amylase particles within the inhalable size fraction [60]. OA
is commonly identiﬁed in workers sensitized to α-amylase.
After bronchial provocation with α-amylase, between 16
and 100% of sensitized workers were found to give a
positive immediate response depending on the study [25,
35, 49]. Nasal provocation with α-amylase in skin prick
test (SPT) positive workers also induced rhinitis [26].
Furthermore, positive associations between α-amylase SPT
and work-related respiratory symptoms have been identiﬁed
[23]. Interestingly, heating α-amylase has been shown to
reduce enzymatic and allergenic activity of the enzyme [76].
Potential sensitization of bakers’ family members due to α-
amylase associated with clothes, shoes, and bakery textiles
has also been reported by Vissers [77].
3.2. γ-Amylase. γ-amylase or glucoamylase is primarily
obtained from A. niger, A. awamori, and R. delemar. Glu-
coamylase is used as a dough additive by bakers, often in
association with α-amylase. The enzyme is also used in the
production of high-glucose syrups [46]. Glucoamylase has a
molecular weight of 68kDa (Table 2) and can remain func-
tionally active at elevated pH. Glucoamylase exposure has
been primarily reported in baking occupations [10, 13, 18];
however, occupational exposure has also been reported in
fruit and salad processing [52]. Sen et al. [52]d e m o n s t r a t e d
that three workers with shortness of breath, chest tightness,
and wheeze had speciﬁc IgE to glucoamylase. Quirce et al.Journal of Allergy 5
[18] also demonstrated positive SPT to glucoamylase in
all tested subjects (n = 4 ) ;h o w e v e r ,o n l yt h r e eo ft h e
four patients elicited an early asthmatic response following
bronchial provocation. Airborne glucoamylase was shown in
9%ofairsamples from abakery[59],and median levelswere
10.3ngm−3. Moderate allergenic cross-reactivity has also
been reported between glucoamylase and α-amylase [18].
3.3. Cellulase, Xylanase, and Hemicellulase. Cellulases are
enzymes that hydrolize cellulose into glucose and are pri-
marily used in the pharmaceutical, baking, detergent, and
textile industries [6, 78]. Cellulase has been puriﬁed from
severalrhizosphere fungi including A. niger and Trichoderma
viride [49], as well as Humicola insolens [41]. The molecular
weight of cellulases ranges from 22 to 45kDa (Table 2).
Cellulases derived from these fungi are used in baking to
break up roughage in dough and as a digestive aid in the
food industry [13, 79, 80]. The ﬁrst case of OA caused
by cellulase was reported in 1981 in a plant pathologist
[49, 81], and later these ﬁndings were conﬁrmed in two
pharmaceutical workers [80], four laboratory workers [14],
andtwo bakers[49].Ineach ofthese studies,theworkershad
speciﬁc IgE to the cellulase antigens. In 171 German bakers,
the prevalence of sensitization to cellulase was 13% [13].
Airborne concentrations of cellulase have been quantiﬁed
using a modiﬁed dot blot technique and were <180ngm−3
in a ﬂour mill, crisp bread factory, and a bakery [82]. OA has
also been reported to cellulase in the baking industry [83]a s
well as from H. insolens used in the detergent industry [41].
Endo1,4-beta-D-xylanase and beta-xylosidase aremajor
enzymes involved in xylan hydrolysis [13]. Collectively
termed xylanases, these enzymes are a type of hemicellulase
that breaks down hemicelluloses, a major component in
plant cell walls [13]. Besides α-amylase, xylanases are the
next most frequently used enzymes in the baking industry
to remove pentosans from bread and increase bread volume
[13, 49]. The prevalence of IgE sensitization to hemicellulase
was reported to be 8% [19] and 11% for xylanase [13].
Sander and colleagues [13]f o u n dt h a t7o f8b a k e r sh a d
serum IgE to a 105kDaprotein in a xylanase ingredient. This
protein was identiﬁed using mass spectrometry to be beta-
xylosidase derivedfromA.niger. The allergen wasdesignated
Asp n 14 by the IUIS Allergen Nomenclature Subcommittee
(Table 2). Airborne concentrations of xylanase have been
reported to be <40ngm−3 in a ﬂourmill and crisp bread
factory [82]. Concentrations as high as 200ngm−3 were also
reported in a bakery, but these values were associated with
the natural xylanase activity of wheat [82]. Case reports
have veriﬁed xylanase sensitization and the presence of an
IgE mechanism in respiratory disease [15, 79]. OA has
also been reported to xylanase in the baking industry [83],
and in a case report, a baker had an immediate asth-
matic response following inhalation challenge [15]. Cross-
reactivity between cellulase and xylanase has been reported
to be in the range of 80–90% but no cross-reactivity has
been shown with α-amylase [13, 14]. Similarly, workers can
also be monosensitized to cellulase and xylanase without
concomitant sensitization to α-amylase [83].
3.4. Lactase. A. oryzae lactase is a high-molecular-weight
protein that is involved in the hydrolysis of the disaccharide,
lactose. Lactase is used in the pharmaceutical industry to
develop dietary aids for patients intolerant to lactose. In a
cross-sectional study of United States pharmaceutical work-
ers, Bernstein and colleagues [38] identiﬁed 29% of lactase-
exposed workers to have positive SPT response to lactase.
Workers with a positive SPT were nine times more likely
to have respiratory symptoms than workers with a negative
SPT [38]. Interestingly, atopy was not associated with the
development of respiratory symptoms. Occupational sensi-
tization to lactase has been reported in workers formulating
and packaging gastrointestinal consumer products [39]. In
inhalational challenge studies conducted by Laukkanin and
colleagues [40], lactase was identiﬁed to induce occupational
IgE-mediated respiratory sensitization. Interestingly, lactase
exposure has also been identiﬁed to cause contact skin
reactions [40].
3.5. Lipase. Lipase is an essential catalyst that digests water-
insoluble lipids. A. oryzae and R. oryzae lipase are used
because of low extraction costs, thermal and pH stability,
substrate speciﬁcity, and activity in organic solvents. Lipase
is predominantly used in the manufacture of laundry
detergents and in baking; however, other newer applications
have been developed. For example, Candida antarctica lipase
hasrecentlybeenusedasabiocatalystforthebiofuelindustry
[84]. The incidence ofoccupational sensitization to lipase, in
industrial settings is understudied. In a preliminary analysis
of detergent manufacturing workers, 3 workers were found
to be sensitized to lipase and bronchial provocation tests
provoked a reproducible asthmatic response [41]. A recent
case study of a pharmaceutical manufacturing worker also
demonstrated sensitization to fungal lipase derived from R.
oryzae but not A. oryzae α-amylase [44].
3.6.Phytase. A.niger andR.oligosporusproducephosphatase
that catalyzes the hydrolysis of phytate to lower-order
phosphateesters[16].Termedphytase,thisenzymeenhances
phosphate bioavailability in the digestive tract and has
been utilized in the animal feed industry during the last
two decades [17]. Phytase accounts for 0.1–1% of total
extractable protein from A. niger [17]. 3-phytase B derived
from A. niger is an 84kDa protein that has been designated
Asp n 25 by the IUIS Allergen Nomenclature Subcommittee
(Table 2). Allergic sensitization to phytase has been reported
in animal feed factory workers (7–90%), and sensitization is
highest at sites where phytase is handled in powdered form
[16, 17, 69, 85]. In a cross-sectional study of 53 technical
center workers that produced A. niger phytase, 52% of
workers in the high-exposure group and only 10% in the
low-exposure group were sensitized tophytase [16].Personal
exposure to phytase has been shown to exacerbate OA, and
inhalation challenge tests produced immediate asthmatic
response [86]. It has been proposed that phytase is highly
sensitizing and that direct contact should be avoided in this
industry [16].6 Journal of Allergy
3.7. Enzymes Used in Health Care Settings: Biodiastase and
Flaviastase. Fungal enzymes have a number of applications
in the healthcare environment. Fungal enzymes derived
from A. niger a r eu s e di np o w d e r e df o r mw i t ho t h e r
enzymeextractsbypharmaciststopreparedigestivepowders.
Biodiastase and Flaviastase are two examples of fungal
enzymes that have been associated with sensitization in
hospital workers and pharmaceutical workers handling these
products [10, 12–21, 23–35, 38–44, 51–88]. To date, health
eﬀects in workers exposed to these enzymes remain poorly
characterized.
3.8. EPg22 Protease: Aspartic Protease. The aspartic proteases
producedby Rhizomucormieheiand Cryphonectria parasitica
are utilized in almost half of the cheese production oper-
ations throughout the world [46]. The proteases assist in
milk clotting and facilitate a change in cheese properties by
hydrolyzing certain peptide bonds. Occupational exposure
to these proteases has been associated with occupational
sensitization in a rennet production plant [11]. Speciﬁcally
29%and6%ofworkershadapositiveskinpricktest(SPT)to
R. miehei and C. parasitica aspartic protease extracts, respec-
tively [11]. Other novel enzymes with potential application
in the food processing industry have been identiﬁed. Pg222
is a novel extracellular protease produced by P. chrysogenum
(Pg222). The enzyme was isolated from dry-cured hams and
was found to have a broad range of applications in industries
that produce dry-cured meat products [89]. Although no
occupational sensitization has been reported to this enzyme,
it demonstrates that the introduction of any new enzyme
could potentially represent an occupational hazard.
4.EmergingOccupationalFungal
Enzyme Exposures
The utility of fungal enzymes to degrade xenobiotics and
organic compounds in the industrial sector continues to
be recognized [46]. Fungal enzymes are now being used
for a variety of purposes across many diﬀerent indus-
tries. Improved biochemical and molecular technologies
have enabled the production of other potentially allergenic
proteins [14]. According to Baur [10], more than 186
commercial enzymes were produced in the European Union
in 2001, and many of these were produced by recombinant
technology or had been genetically engineered. Table 1
provides a summary of the major fungal enzymes that are
utilized in industrial settings. All of the aforementioned
enzymes that are listed in Table 1 have been identiﬁed to
be potent allergens in the workplace; however, the ability of
the other listed enzymes to cause adverse health outcomes
following occupational exposure remains unclear.
Several of the enzymes presented in Table 1,n o ti d e n t i -
ﬁed as occupational allergens, have been identiﬁed as aller-
gens associated with environmental bioaerosols. Catalase,
a fungal enzyme utilized in hygiene products, pharmaceu-
ticals, and textiles, has been identiﬁed as an allergen in
the entomopathogenic fungus, Metarhizium anisopliae [90].
Pectinase is used in brewing and wine production, food
processing, and paper industries and allergy to pectinase has
been associated with occupational exposure [91]. Esterase
has been identiﬁed as an allergen in Hevea brasiliensis (natu-
ral rubber latex) [92]. Beta-glucanase is used to improve the
nutritional yield of animal feeds, and occupational exposure
has been shown in a case study to signiﬁcantly reduce
forced vital capacity and forced expired volume in 1 second
(FEV1) [86] .T h ew o r k e ri nt h i sc a s es t u d yw a sa l s oS P T
positive and had speciﬁc IgE to beta-glucanase [86]. In the
biotechnologyandpharmaceuticalindustries,glutathione-S-
transferase (GST) has a number of applications. GST is an
approximately 26kDa protein that has been identiﬁed as a
major Alternaria alternata allergen and is highly conserved
across fungi [45, 93, 94]. The IUIS Allergen Nomenclature
Subcommittee has designated this allergen Alt a 13 [93, 94].
Interestingly, alpha-galactosidase has been associated with
delayed anaphylaxis, angioedema, or urticaria in sensitized
patients following the ingestion of beef, pork, or lamb [95].
Although the role of alpha-galactosidase and these other
enzymes following occupational exposure remains unclear,
these studies provide preliminary insight into the possible
potency of these allergens in industrial environments.
5.Immunodiagnostic DetectionMethodologies
Occupational allergic sensitization to fungal enzymes is
diagnosed clinically using available in vivo SPT reagents, or
in vitroassays suchasPhadia ImmunoCap[7].However,SPT
reagents for most of the fungal enzymes used in industrial
settings are not commercially available and have to be either
custom ordered or prepared individually by the investigator.
Methods for SPT extract preparation that are used by
investigators in the ﬁeld have been previously described by
Quirce et al. [49]. In vitro diagnostic tools that can quantify
the amount of speciﬁc IgE to an occupational allergen are
not readily available except in research laboratories where
investigators prepare their own inhibition or radioaller-
gosorbent enzyme-linked immunosorbent assay (ELISA) to
quantify speciﬁc IgE [36, 49]. To date, α-amylase (k87) is
the only fungal enzyme available on the Phadia ImmunoCap
testing panel. To conﬁrm OA caused by fungal enzymes,
bronchial provocation tests can be undertaken to document
immediate or late-phase responses to fungal enzymes [36,
49]. Positive immediate response criteria used in workers
exposed to enzymes include a greater than 20% fall in FEV1,
whereas a late-phase response has been considered positive
when there is a 30% or greater fall in peak expiratory
ﬂow rate [49]. However, there are several limitations with
bronchial provocation tests that should be considered; these
are discussed in detail by Peden and Reed [7].
In order to better understand the relationships between
occupational fungal enzyme exposure and clinical symp-
tomology, accurate information on the distribution and
quantity of the fungal enzyme in the occupational envi-
ronment will be required. Immunodiagnostic methods that
utilize antibodies could provide standardized methods for
quantifying fungal enzyme biomarkers in a variety ofJournal of Allergy 7
occupational environments. Following validation and inter-
laboratorycomparison,theassays couldbeused forexposure
assessment to determine the existence of exposure-response
relationships [58, 96]. This information is critical for the
development of future threshold limit values (TLVs) and
other occupational standards.
Several antibodies and immunodiagnostic methods have
been produced to detect industrial fungal enzymes, in
particular α-amylase. These methods have been employed in
ﬁeld investigations and used to quantify the concentration of
theenzymefromcollectedairsamples. Bogdanovicetal.[97]
used an enzyme immunoassay with a sensitivity of 25pg/mL
to quantify α-amylase in airborne and surface dust samples
collected from ﬁve bakeries. In the same study, a lateral ﬂow
immunoassay for α-amylase was compared to the reference
enzyme immunoassay. The sensitivity of the lateral ﬂow
assay was 1–10ng/mL, and extracts with >5ng/mL allergen
were positive in the lateral ﬂow assay [97]. In a study of
507 personal air samples, Houba and colleagues [60]u s e d
a rabbit IgG capture immunoassay to quantify α-amylase in
speciﬁc baking job category. Concentrations of α-amylase up
to 40ngm−3 were quantiﬁed, and workers directly involved
with dough preparation had the highest exposures [60].
Using the same rabbit IgG sandwich assay, Nieuwenhuijsen
et al. [55] identiﬁed dispensing and mixing areas to have
the highest α-amylase exposure in British bakeries and ﬂour
mills. Two monoclonal antibody- (mAb-) based ELISAs
have been developed for the detection of α-amylase in the
occupational environment. Assay sensitivities ranged from
0.2ng/mL [98]t o0 . 6 n g / m L[ 99]. A quantitative mAb-
mediated dot blot assay has also been previously described
for cellulase and xylase; the detection limits reported were
20ngm−3 and 2ngm−3, respectively [82]. mAbs to other
fungal enzymes, such as xylanase have been produced and
reported in the literature [100]. Similarly, the detergent
industry has produced antibodies and immunoassays for
severalcommon fungal enzymesand thesehavebeenutilized
in industrial hygiene safety programs to mitigate worker
exposures [101–103]. Unfortunately, for many other fungal
enzymes presented in Table 1, there are no commercially
available antibodies to enable quantiﬁcation in the occu-
pational environment. The development of fungal enzyme-
speciﬁc mAbs in combination with immunodiagnostic tech-
niques will further our knowledge of the exposure-response
relationships in occupational environments. Using these
methods will also help enable the development of standards
and focus on the prevention of sensitization in heavily
contaminated work environments.
6.AllergenAvoidanceand Directionsfor
theFuture
Exposure to fungal enzymes, in particular α-amylase, is a
considerable health risk in a number of industries. Cross-
sectional studies have shown that processing workers in
high-exposure categories who handled fungal enzymes are
up to ten times more likely to be sensitized to fungal
enzymes than workers in the low-exposure category [55].
Highest concentrations of enzymes in the inhalable fraction
were encountered among workers located in dispensing,
mixing, weighing, and sieving occupations [54–56, 60].
Airborne concentrations as high as 40ngm−3 and in some
c a s e se v e nh i g h e r( 2 0 0 n g m −3) have been reported for
sensitized workers located in these handling areas [12, 55,
60]. Concentrations in the low ngm−3 range have been
associated with an increased frequency of sensitization [58].
For other fungal enzymes, such as phytase, similar ﬁndings
have been reported [16].
The continued utilization of other previously overlooked
enzymes as well as new genetically engineered enzymes in
various industries will continue to provide diagnostic chal-
lenges, even for the most seasoned occupational medicine
professional.Itislikelythatnewcasesofoccupationalallergic
disease will emerge following exposure to fungal industrial
enzymes during the next decade. In response, identiﬁcation
of exposure-response relationships will be critical for the
development of TLVs and occupational exposure levels.
However, this will depend on the development of suitable
diagnostic antibodies and immunoassays. Currently, subtil-
isin, a sereine endopeptidase derived from Bacillus subtilis,i s
the onlyenzyme for which the American Conferenceof Gov-
ernmental Industrial Hygienists (ACGIH) has established a
TLV value (60ngm−3). The European Union Directive also
classiﬁes the fungal enzymes cellulase and α-amylase with
the risk phrase R42 (may cause sensitization by inhalation)
[10]. There are currently no consensus standards for other
industrially utilized fungal enzymes.
As a precautionary measure, it has been concluded that
all enzymes should be regarded as an allergen that can exac-
erbate respiratory sensitization in susceptible populations
[10, 59]. Baur [10] has further proposed that all enzymes
should be classiﬁed as R42 according to the European Union
Directivecriteria.Althoughinterventioninthebakeryindus-
tryhashadlittletonoeﬀect[104],installationofengineering
controls and implementation of personal protective equip-
ment programs in animal feed workers exposed to phytase
was shown to result in the immediate cessation of hyper-
sensitivity symptoms [10]. Improvements in biotechnology
have also included the encapsulation of some enzymes [105,
106] and proteins [107]. These engineering controls have
been proposed to reduce occupational exposure to enzymes;
however, encapsulation alone may not completely prevent
enzyme-induced allergy and OA [108, 109]. To date, the
detergentindustry hasimplementedaderivedminimal eﬀect
level (DMEL) of 60ngm−3 for pure enzyme proteins [110].
Although this DMEL was provided as guidance by the
ACGIH, other manufacturers have implemented their own
occupationalexposureguidelines(OEGs)forfungalenzymes
such as α-amylase (5–15ngm−3), lipase (5–20ngm−3), and
cellulase (8–20ngm−3)[ 110]. In addition, the detergent
industry has developed a medical surveillance program to
identify and correct elevated exposures before occupational
illnesses occur [101–103, 111]. As a result, the incidence of
occupational allergy has dropped substantially [101–103].
Implementation of DMELs and OEGs will further assist in
thereductionofoccupationalexposure.Reducingworkerex-
posure to fungal enzymes in industry by the implementation8 Journal of Allergy
of engineering controls and other allergen avoidance strate-
gies will continue to mitigate personal exposure and further
reduce the occupational health risk.
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